Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02659020
Title A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Acronym ANNOUNCE 2
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups:
Covered Countries USA | POL | ITA | ISR | HUN | GBR | FRA | ESP | DEU | AUS


No variant requirements are available.